| Primary |
| Nutritional Supplementation |
100.0% |
|
| Respiratory Tract Congestion |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
35.4% |
| Drug Use For Unknown Indication |
20.8% |
| Blood Triglycerides Increased |
4.2% |
| Hypertension |
4.2% |
| Pulmonary Arterial Hypertension |
4.2% |
| Anaemia |
2.1% |
| Ankle Swelling |
2.1% |
| Arthritis |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Blood Potassium Decreased |
2.1% |
| Blood Pressure High |
2.1% |
| Depression |
2.1% |
| Fluid Retention |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Gout |
2.1% |
| Heart Rate Decreased |
2.1% |
| High Cholesterol |
2.1% |
| Joint Swelling |
2.1% |
| Psoriasis |
2.1% |
| Thrombosis |
2.1% |
|
| Loss Of Consciousness |
25.0% |
| Urticaria |
25.0% |
| Ecchymosis |
12.5% |
| Rash |
12.5% |
| Visual Acuity Reduced Transiently |
12.5% |
| Vitamin D Deficiency |
12.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.6% |
| Drug Use For Unknown Indication |
16.3% |
| Osteoporosis |
6.1% |
| Hypertension |
3.9% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.5% |
| Blood Cholesterol Increased |
2.8% |
| Asthma |
2.5% |
| Osteopenia |
2.5% |
| Atrial Fibrillation |
2.2% |
| Hepatitis C |
2.2% |
| Arthritis |
1.9% |
| Diabetes Mellitus |
1.7% |
| Coronary Artery Disease |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Anxiety |
1.5% |
| Blood Cholesterol |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Depression |
1.5% |
| Hypercholesterolaemia |
1.5% |
|
| Weight Decreased |
14.0% |
| Drug Ineffective |
9.7% |
| Nausea |
6.5% |
| Myalgia |
5.4% |
| Pain |
5.4% |
| Weight Increased |
5.4% |
| Wheezing |
5.4% |
| Pain In Extremity |
4.3% |
| Product Quality Issue |
4.3% |
| Tachycardia |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.3% |
| Ventricular Extrasystoles |
4.3% |
| Weight Bearing Difficulty |
4.3% |
| Insomnia |
3.2% |
| Iron Deficiency Anaemia |
3.2% |
| Myocardial Infarction |
3.2% |
| Oedema Peripheral |
3.2% |
| Pneumonia |
3.2% |
| Rash |
3.2% |
| Somnolence |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
23.8% |
| Hypertension |
9.5% |
| Pulmonary Arterial Hypertension |
9.5% |
| Anaemia |
4.8% |
| Arthritis |
4.8% |
| Blood Cholesterol Increased |
4.8% |
| Blood Potassium Decreased |
4.8% |
| Depression |
4.8% |
| Fluid Retention |
4.8% |
| Gastrooesophageal Reflux Disease |
4.8% |
| Gout |
4.8% |
| Heart Rate Decreased |
4.8% |
| Herpes Virus Infection |
4.8% |
| Joint Swelling |
4.8% |
| Thrombosis |
4.8% |
|
| Drug Interaction |
25.0% |
| Loss Of Consciousness |
25.0% |
| Road Traffic Accident |
25.0% |
| Urticaria |
25.0% |
|
